China's feverish stockmarket weighs the cost of the coronavirus

China’s stockmarket fell by 8% in one day – the biggest daily fall in more than four years. But investors shouldn't panic.

The economic effect of the coronavirus could be four times greater than the cost of Sars
(Image credit: AFP via Getty Images)

China’s stockmarket has recorded its biggest daily fall in more than four years. The CSI 300 plunged by 7.9% on Monday, its first day of trading since the coronavirus (2019-nCoV) outbreak came to dominate international headlines. Hong Kong’s Hang Seng index is down by 6.5% so far this year. The FTSE 100 has fallen 3.5% since the start of January.

Gauging the damage to growth

Try 6 free issues of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up for MoneyWeek’s free twice-daily newsletter.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Sign up
Latest Videos FromMoneyWeek
Markets editor

Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019. 

Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere. 

He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful. 

Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.